HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Cosmederm Technologies

This article was originally published in The Rose Sheet

Executive Summary

Cosmederm Technologies: Signs licensing agreement with Collagen Corp. for use of its Cosmederm-7 anti-irritant ingredient in a line of dermatologically positioned AHA products. Collagen is planning to introduce Refinity Medical Solutions in early 1998, with products including a purifying cleanser, protective toner, rejuvenating lotion, cream and hydrogel. Cosmederm said Collagen was interested in Cosmederm-7 as a "highly effective" suppressant of "stinging, burning, itching and inflammation." Terms of the deal were not disclosed...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004821

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel